Publication | Open Access

MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis

InflammationMitophagyAutoimmune DiseaseDisease ProgressionAllergyMedicineImmunologyAutophagyCell DeathAutoimmunityMultiple SclerosisMitochondria-targeted AntioxidantNeuroimmunologyOxidative StressNeuroinflammation